Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #85779 on PharmaCyte Biotech Inc (PMCB)
1234jklm
08/18/18 9:33 PM
#85780 RE: Kimori #85779
As concerns mount over outlays for prescription drugs, a new report finds that global spending on oncology treatments reached $100 billion last year, which represented a 10.3% increase from the previous year and a substantial rise from $75 billion spent five years ago.May 5, 2015
Current checkpoint inhibitors each have a list price near $150,000 a year. A combination of Yervoy and Opdivo, approved by the Food and Drug Administration for advanced or inoperable melanoma, has a cost of $256,000 a year for patients who respond to the treatment.Apr 3, 2017[/quote And this is a current and unmet medical need in the case of pancreatic cance And then there’s diabetes:
According to the leading diabetes website, the American Diabetes Association, the cost associated with diagnosed diabetes was $245 billion in 2012 compared to $174 billion in 2007. That is a 41% increase in just a period of five years. Out of the $245 billion, $176 billion were the direct medical costs of diabetes.Jul 12, 2018